REGEN BIOPHARMA, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $2.1M | $598.5K | $113.2K |
| Jun 2017 | $5.0M | $965.6K | $401.6K |
| Sep 2017 | $6.2M | $944.2K | $270.0K |
| Dec 2017 | $8.9M | $1.1M | $261.7K |
| Mar 2018 | $9.6M | $757.1K | $31.1K |
| Jun 2018 | $9.1M | $558.8K | $55.4K |
| Sep 2018 | $9.3M | $209.0K | $8.0K |
| Dec 2018 | $8.8M | $182.2K | $39.1K |
| Mar 2019 | $8.9M | $43.9K | $15.1K |
| Jun 2019 | $12.9M | $114.3K | $1.8K |
| Sep 2019 | $11.0M | $99.1K | $7.9K |
| Dec 2019 | $7.7M | $41.0K | $357 |
| Mar 2020 | $8.7M | $95.5K | $0 |
| Jun 2020 | $8.7M | $95.5K | $0 |
| Sep 2020 | $7.5M | $123.2K | $0 |
| Dec 2020 | $5.7M | $150.6K | $0 |
| Mar 2021 | $5.2M | $178.0K | $0 |
| Jun 2021 | $13.8M | $1.4M | $188.2K |
| Sep 2021 | $14.7M | $1.2M | $727.2K |
| Dec 2021 | $10.5M | $735.2K | $353.5K |
| Mar 2022 | $77.4M | $630.9K | $234.7K |
| Jun 2022 | $9.0M | $689.7K | $111.0K |
| Sep 2022 | $8.6M | $559.0K | $51.2K |
| Dec 2022 | $5.3M | $414.1K | $40.7K |
| Mar 2023 | $5.3M | $406.6K | $87.7K |
| Jun 2023 | $5.3M | $285.2K | $692 |
| Sep 2023 | $5.5M | $353.6K | $121.0K |
| Dec 2023 | $5.4M | $159.5K | $124.5K |
| Mar 2024 | $5.3M | $140.8K | $78.1K |
| Jun 2024 | $5.3M | $170.2K | $61.8K |
| Sep 2024 | $5.4M | $161.1K | $716 |
| Dec 2024 | $5.9M | $191.4K | $135 |
| Mar 2025 | $5.9M | $169.5K | — |
| Jun 2025 | $6.0M | $196.8K | — |
| Sep 2025 | $6.6M | $274.6K | $69.6K |
| Dec 2025 | $6.8M | $237.1K | $4.6K |
| Mar 2026 | $5.6M | $260.2K | $271 |
| Jun 2026 | $6.2M | $287.6K | $239 |